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Abstract
A decade has passed since metabolic syndrome (MetS) was documented to be highly prevalent in the kingdom of
Saudi Arabia. No follow-up epidemiologic study was done. This study aims to fill this gap. In this cross-sectional,
observational study, a total of 2850 randomly selected Saudi adults aged 18–55 years were recruited. Subjects’
information was generated from a database of more than 10,000 Saudi citizens from the existing Biomarkers
Screening in Riyadh Program (RIYADH Cohort), Saudi Arabia. Anthropometrics included body mass index (BMI),
blood pressure, as well as waist and hip circumferences. Fasting blood glucose and lipid profile were determined
using routine laboratory procedures. The definition of ATP-III (NHANES III) was used for the diagnosis of the full
MetS. The overall prevalence of complete MetS was 35.3% [Confidence-Interval (CI) 33.5–37.01]. Age-adjusted
prevalence according to the European standard population is 37.0%. Low HDL-cholesterol was the most prevalent of
all MetS risk factors, affecting 88.6% (CI 87.5–89.7) and hypertriglyceridemia the second most prevalent, affecting
34% (CI 32.3–35.7) of the subjects. The prevalence of the full MetS decreased from previous estimates but remains
high, while dyslipidemia remains extremely high, affecting almost 90% of middle-aged Arabs. Screening
for dyslipidemia among Saudi adults is warranted, especially among those most at risk. Scientific inquiry into
the molecular causes of these manifestations should be pursued as a first step in the discovery of etiologic
therapies.
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Introduction
Metabolic syndrome (MetS), which is the clinical term used
for the co-occurrence of several cardiovascular risk factors, is
quite prevalent in many developed nations. Al-Nozha and
colleagues previously reported that MetS was almost 40%
among adults in a kingdom-wide sample population taken from
1995–2000 [1]. Since then, other epidemiologic studies
conducted within the Arab Peninsula confirmed the same high
prevalence [2–4]. Aside from the conventional risk factors for
MetS which include over nutrition and sedentary lifestyle, other
risk factors peculiar to the Arab population have been
identified. These include acute post cessation smoking [5],
and metabolic abnormalities such as altered adipocytokine
levels [6], particularly leptin [7], and homocysteine [8]. A
decade has passed, however, and no follow-up epidemiologic
study was done in the Saudi Arab population to determine
whether the epidemic has been addressed properly. This study
aims to determine the prevalence of MetS in a cohort of adult
Saudis living in urban areas and to identify which are the most
prevalent MetS components.
Materials and Methods
Subjects
In this cross-sectional community-based study, a total of 2,850
Saudi adults aged 18–55 years were included. Subjects were part of
the capital-wide Biomarker Screening in Riyadh (BSR), a collabora-
tive effort between the Biomarkers Research Program (BRP) of King
Saud University (KSU) and the Ministry of Health in Riyadh,
Kingdom of Saudi Arabia (RIYADH Cohort). Ethical approval was
obtained from the College of Medicine Research Center Ethics
Committee of KSU, Riyadh, KSA. In brief, BSR was launched to
identify and employ novel biomarkers of chronic non-communicable
diseases, including diabetes mellitus (DM), cardiovascular diseases
(CVD), and obesity, among consenting Saudis. Subjects were
recruited randomly from different Primary Health Care Centers
(PHCC) across Riyadh. No expatriates were included in the conduct
of this study. Each participating subject submitted a signed consent
form, a general questionnaire containing demographic, past and
present medical history, as well as diet information from the food
frequency questionnaire. Subjects’ information was taken from the
existing database of more than 10,000 subjects (RIYADH Cohort).
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Consenting adults were invited to their respective PHCC after a
10 h overnight fasted state. Anthropometric measurements
included height (cm), weight (cm), waist (cm) and hip (cm)
circumferences and were taken and noted by trained nurses.
Systolic and diastolic blood pressures were taken twice with a 15-
minute interval. The average of both readings was recorded. Body
mass index (BMI) was calculated as weight (kg) over height (m
2).
Biochemical measurements
Blood was drawn, centrifuged and processed in the same day.
Both whole blood and serum were placed in plain polystyrene
tubes and delivered to BRP for storage at22uC. Fasting blood
glucose, triglycerides, and HDL cholesterol were quantified using
routine laboratory analysis (Konelab, Finland). This biochemical
analyzer (Konelab) was calibrated routinely prior to the analysis of
all serum samples using quality control samples provided (Thermo
Fisher Scientific, Finland). Glucose test method employed glucose
oxidase and modified Trinder color reaction catalyzed by the
enzyme peroxidase. Triglycerides test method employed hydroly-
sis, phosphorylation and oxidation leading to the formation of
quinoeimine dye which is absorbed at 510 nm. HDL-cholesterol
test method employed homogenous enzymatic colorimetric test by
cholesterol oxidase coupled with poly(ethylene-glycol) to the amino
groups. Measurement ranges were as follows: glucose (0.3–
20.0 mmol/L); triglycerides (0.05–11.0 mmol/L), HDL-cholester-
ol (0.16–2.80 mmol/L). All samples fell within normal detection
limits. Standard International Units (mmol/L) were used to record
the results. For validation purposes, randomized samples were sent
to a reference lab within the kingdom (King Faisal Specialist
Hospital and Research Center, Riyadh, KSA).
Definition of MetS
The definition of MetS used was according to the National
Cholesterol Education Program-Third Adult Treatment Panel
(NCEP ATP III), three or more of the following criteria must be
fulfilled: fasting blood glucose level $5.6 mmol/l; blood pressure
$130/85 mm Hg; triglycerides $1.7 mmol/l; HDL cholesterol
,1.03 mmol/l for men and ,1.29 mmol/l for women; and waist
circumference .102 cm for men and .88 cm for women [9].
Data Analysis
Statistical analysis was done using the Statistical Package for
Social Sciences (SPSS) version 11.5 (Chicago, Illinois). Continuous
variables are shown as mean 6 standard deviation. Age
adjustment was done with a European standard population.
Frequencies were presented as percentage (confidence-interval).
MetS prevalence was presented as overall prevalence, age-adjusted
prevalence and prevalence according to age.
Results
The over-all prevalence of MetS was 35.3% (CI 33.5–37.01),
while an age adjusted prevalence was almost 37.0%. Low HDL-
cholesterol remains the most common MetS component with
almost 9 out of 10 [88.6% (CI 87.5–89.7)] of subjects affected
followed by hypertriglyceridemia with an over-all prevalence of
34% (CI 32.3–35.7) (Table 1). Males had significantly higher
prevalence of high blood pressure, impaired fasting glucose and
triglycrides (p-values 0.004, 0.001,0.001 respectively) while
females had significantly higher prevalence of abdominal obesity
(p-value ,0.001). Figure 1 shows the alarmingly increasing
prevalence of MetS with age, with the age group 50–55 years
harboring MetS in almost 6 out of 10 adults. Figures 2 and 3 show
the persistent high prevalence of low-HDL-cholesterol and
hypertriglyceridemia even after stratification for age, respectively.
Discussion
There is some improvement in the prevalence of MetS in the
kingdom, particularly in Riyadh region where the study was
conducted. Prevalence of MetS in urban areas was previously
recorded at 44.1% (1) compared to 37.0% in the present study.
The prevalence of dyslipidemia as evidenced by low HDL-
cholesterol and high triglyceride levels, however, remained
alarmingly high, continuing to be the most common cardiovas-
cular risk factor among Saudi adults. High prevalence of low
HDL-cholesterol was also noted among the elderly in Spain [10]
and adults in Nigeria [11], but the prevalence is significantly less
than that shown in the present study. This calls for further
assessment in terms of possible genetic and epigenetic variations
within the population. One way to explore this issue is to address
genetic determinants of HDL-cholesterol concentrations. Choles-
teryl ester transfer protein (CETP), which is detectable at Taq1,
was noted to have relatively modest impact on HDL-concentra-
tions among Saudis [12]. The aplolipoprotein B/apolipoprotein
A1 ratio on the other hand, was inversely associated to HDL-
cholesterol levels and were also associated with components of
MetS among Saudis [13]. All in all, little has been done to address
the issue of extremely high prevalence of low-HDL cholesterol in
the kingdom in terms of identification of causes and early
intervention measures. This lack of emphasis has, therefore,
translated to the same lack of improvement in terms of decreased
Table 1. Prevalence of Individual Components and of the Full MetS in the Urban Saudi Arab Population (Adult criteria NCEP
ATP III [9]).
Total Males Females P-Value
N 2850 1335 1515
Low HDL-Cholesterol 88.6 (87.5–89.7) 89.4 (87.8–91.0) 87.8 (86.2–89.4) 0.168
High Blood pressure 25.4 (23.7–27.1) 28.2 (25.6–30.8) 23.1 (20.9–25.3) 0.004
Impaired Fasting Glucose 29.9 (28.3–31.5) 33.0 (30.5–35.5) 27.1 (24.9–29.3) 0.001
Elevated Triglycerides 34.0 (32.3–35.7) 42.0 (39.4–44.6) 27.0 (24.8–29.2) ,0.001
Abdominal obesity 39.1 (37.8–40.9) 29.0 (26.5–31.5) 47.8 (45.3–50.3) ,0.001
Prevalence of Full MetS 35.3 36.6 34.1 0.176
Note: Data presented as percentage (confidence interval 95%). Significant at p,0.05.
doi:10.1371/journal.pone.0012159.t001
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extended region as well. Parent-offspring transmission-wise,
heritability of MetS components had been previously documented
among Omani families with strong tendencies for higher BMI,
lower HDL-C and larger body weight while higher triglycerides,
diastolic BP, abdominal obesity and insulin resistance were more
environmentally driven [14]. Extremely high prevalence of low
HDL-C has also been documented among Saudi children,
affecting ,90% of them [15]. Low HDL-C had the highest
heritability among Caucasian individuals [16–17] and Korean
twins [18].
While the prevalence of MetS in males is higher, it is not
significantly different from females. Similar findings were found in
a recent study by Lin and colleagues, where even if a higher
prevalence of MetS among males was observed, the mortality risk
was greater among postmenopausal women [19]. Gender
differences among the components of MetS are influenced by
sex hormones. Indeed, gonadal hormones are directly involved in
both glucose and lipid metabolism, with decreased levels of
estrogen and/or higher levels of testosterone being associated with
insulin resistance and a proatherogenic lipid profile, which makes
the male gender by itself a risk factor for cardiovascular disease
[20]. Furthermore, this difference may also arise from other factors
previously not mentioned which are common among the Saudi
male population, such as smoking [21]. Going back to figure 1,
males have a higher prevalence of MetS only among the younger
age groups, and females eventually catch up once menstruation
has ceased, since the cardioprotective effects of the estrogen cycle
is lost. Consequently, females have a higher prevalence of obesity
than males, and this is true for the rest of the Arabian Gulf States
[22].
In summary, the prevalence of the full MetS among urban
Saudi adults remains high, but has considerably decreased.
Prevalence of low-HDL cholesterol on the other hand remains
Figure 2. Prevalence of low HDL-cholesterol stratified according to age (adult criteria NCEP ATP III [9]).
doi:10.1371/journal.pone.0012159.g002
Figure 1. Prevalence of MetS in males and females according to age groups (adult criteria NCEP ATP III [9]).
doi:10.1371/journal.pone.0012159.g001
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intervention and further scientific exploration.
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